Alogliptin after acute coronary syndrome in patients with type 2 diabetes: a renal function stratified analysis of the EXAMINE trial

被引：0
|
作者：
João Pedro Ferreira
Cyrus Mehta
Abhinav Sharma
Steven E. Nissen
Patrick Rossignol
Faiez Zannad
机构：
[1] Université de Lorraine,Division of Cardiology
[2] Centre d’Investigations Cliniques Plurithématique Inserm 1433,Cleveland Clinic Coordinating Center for Clinical Research, Department of Cardiovascular Medicine
[3] Nancy,undefined
[4] France,undefined
[5] CHRU de Nancy,undefined
[6] Inserm U1116,undefined
[7] Nancy,undefined
[8] France,undefined
[9] FCRIN INI-CRCT,undefined
[10] INSERM U1116,undefined
[11] CHRU,undefined
[12] F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists),undefined
[13] Cytel Corportation,undefined
[14] Harvard T.H. Chan School of Public Health,undefined
[15] McGill University Health Centre,undefined
[16] McGill University,undefined
[17] Cleveland Clinic,undefined
来源：
BMC Medicine | / 18卷
关键词：
Alogliptin; Renal function; Stratification; Outcomes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] TAILORED SUPPORT FOR TYPE 2 DIABETES PATIENTS WITH AN ACUTE CORONARY SYNDROME AFTER DISCHARGE FROM HOSPITAL
    Kasteleyn, M.
    Gorter, K.
    Rutten, G.
    INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2012, 19 : S122 - S122
  • [42] N-Terminal-pro-Brain Natriuretic Peptide Decreases Following Treatment with Alogliptin in Patients with Type 2 Diabetes and Recent Acute Coronary Syndromes: Results from EXAMINE
    Zannad, Faiez
    Cannon, Christopher P.
    Cushman, William C.
    Bakris, George L.
    Nissen, Steven E.
    Morrow, David A.
    Heller, Simon K.
    Bergenstal, Richard M.
    Perez, Alfonso T.
    Fleck, Penny R.
    Mehta, Cyrus R.
    Kupfer, Stuart
    Lam, Hung
    Wilson, Criag
    White, William B.
    CIRCULATION, 2014, 130
  • [43] Recurrent Cardiovascular Events in Patients with Type 2 Diabetes after Hospitalization for Acute Coronary Syndrome: The Fremantle Diabetes Study
    Davis, Wendy A.
    Davis, Timothy M. E.
    DIABETES, 2015, 64 : A679 - A679
  • [44] Commentary: Baseline adiponectin concentration and clinical outcomes among patients with diabetes and recent acute coronary syndrome in the EXAMINE trial
    Broz, Jan
    Brabec, Marek
    Kvapil, Milan
    Polak, Jan
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [45] Cardiovascular outcomes of vildagliptin in patients with type 2 diabetes mellitus after acute coronary syndrome or acute ischemic stroke
    Chen, Dong-Yi
    Li, Yan-Rong
    Mao, Chun-Tai
    Tseng, Chi-Nan
    Hsieh, I-Chang
    Hung, Ming-Jui
    Chu, Pao-Hsien
    Wang, Chao-Hung
    Wen, Ming-Shien
    Cherng, Wen-Jin
    Chen, Tien-Hsing
    JOURNAL OF DIABETES INVESTIGATION, 2020, 11 (01) : 110 - 124
  • [46] Lixisenatide in Type 2 Diabetes and Acute Coronary Syndrome
    Derosa, Giuseppe
    Maffioli, Pamela
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (11): : 1095 - 1095
  • [47] ASSESSMENT OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH TYPE II DIABETES AFTER ACUTE CORONARY SYNDROME
    Andrews, K. L.
    Lumsden, N. G.
    Moore, X. L.
    Shaw, J. A.
    Kaye, D. M.
    Sampson, A. K.
    Dart, A. M.
    Bobadilla, M.
    Mizrahi, J.
    Chin-Dusting, J. P. F.
    HYPERTENSION, 2012, 60 (02) : 496 - 496
  • [48] Endothelial dysfunction in patients with type 2 diabetes post acute coronary syndrome
    Lumsden, Natalie G.
    Andrews, Karen L.
    Bobadilla, Maria
    Moore, Xiao L.
    Sampson, Amanda K.
    Shaw, James A.
    Mizrahi, Jacques
    Kaye, David M.
    Dart, Anthony M.
    Chin-Dusting, Jaye P. F.
    DIABETES & VASCULAR DISEASE RESEARCH, 2013, 10 (04): : 368 - 374
  • [49] Lixisenatide - Therapy in Patients with Type-2-Diabetes and acute Coronary Syndrome
    Kahl, S.
    DIABETOLOGE, 2016, 12 (01): : 42 - 43
  • [50] Conservative treatment for acute coronary syndrome in patients with type 2 diabetes mellitus
    Kakorin, S., V
    Kruglyy, L. B.
    Mkrtumyan, A. M.
    DIABETES MELLITUS, 2013, 16 (02): : 43 - 51
12345